Sutro Biopharma (STRO) PT Raised to $35 at Citizens Ahead of AACR Conference

April 17, 2026 7:19 AM

Citizens analyst Reni Benjamin raised the price target on Sutro Biopharma (NASDAQ: STRO) to $35.00 (from $23.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found